Tips for Traveling with Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

People travel for many reasons – to see family, for business purposes, to...see more explore new sites or just to relax and unwind. Traveling often brings unexpected challenges, especially for those with Parkinson’s disease (PD). However, with proper and proactive planning, there is no need to let PD hold you […]

Read More

Making Hope Possible: APDA Supports Researchers with $4.04 Million in New Funding

Posted on by Rebecca Gilbert, MD, Ph.D.

Supporting Innovative Scientists and Breakthrough Discoveries The American Parkinson Disease Association (APDA) proudly announces $4.04 million in new funding...see more for cutting-edge Parkinson’s disease (PD) research – representing a 55% increase in research funding from the previous year. These new awards support a remarkable group of scientists, each dedicated to advancing our understanding of PD and […]

Read More

Brain Imaging for Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

Parkinson’s disease (PD) is typically diagnosed based on clinical exam, but there are imaging tests that are available to...see more help in diagnosis. The most commonly known in the US is the Dopamine Transporter Scan (DaTscan), an imaging test in which a radioactive tracer, Ioflupane (123I) — which is also called DaTscan — is injected into the […]

Read More

How People with Parkinson’s Disease Can Minimize Risks During Hospitalization

Posted on by Rebecca Gilbert, MD, Ph.D.

Hospitalization can be stressful and challenging for anyone, but for people living with Parkinson’s disease (PD), a hospital stay...see more can present unique risks. It is important for patients and their loved ones to be prepared for these situations in order to mitigate issues that may arise and have a chance at the best possible outcome. […]

Read More

Adaptive Deep Brain Stimulation: A New Era in Parkinson’s Disease Treatment

Posted on by Rebecca Gilbert, MD, Ph.D.

How Adaptive DBS Aims to Offer More Personalized and Effective Therapy When the Food and Drug Administration (FDA) approved...see more deep brain stimulation (DBS) for Parkinson’s disease (PD) in 2002, it revolutionized the PD treatment landscape. DBS has since become a very effective therapy for certain patients whose symptoms are no longer adequately controlled by medication […]

Read More

Nanocarrier Breakthrough Offers Hope for Parkinson’s Disease Treatment

Posted on by Rebecca Gilbert, MD, Ph.D.

How Nanocarriers Overcome a Major Hurdle in Parkinson’s Treatment Delivering medications to the brain is one of the most...see more significant challenges in modern medicine. The brain is protected by an incredibly selective shield known as the blood-brain barrier (BBB), a defense mechanism that keeps out toxins and harmful agents but also prevents many therapeutic drugs […]

Read More

Exploring Non-Invasive Neuromodulation for Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

What is neuromodulation and how can it be used to treat Parkinson’s disease? Medication remains the primary method of...see more treating Parkinson’s disease (PD). However, neuromodulation, or therapies that involve the manipulation of brain circuitry, can also be very effective in controlling PD symptoms in particular clinical situations. Two current neuromodulatory techniques for PD are deep […]

Read More

Parkinson’s Disease Research Insights from Dr. J. Timothy Greenamyre

Posted on by Rebecca Gilbert, MD, Ph.D.

Shaping the Future of Parkinson’s Treatment: Dr. Greenamyre’s Contributions and Outlook The American Parkinson Disease Association (APDA) is committed...see more to furthering Parkinson’s disease (PD) research and proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and finding the cure(s) for PD. Our Centers for Advanced Research, along with […]

Read More

How AI is Revolutionizing Parkinson’s Research and Clinical Care

Posted on by Rebecca Gilbert, MD, Ph.D.

Understanding AI: A Powerful Tool in the Fight Against Parkinson’s Disease Artificial Intelligence (AI) is all around us and...see more becoming more and more ubiquitous in many aspects of our lives, including Parkinson’s disease (PD) research and clinical care. But what exactly is AI, and how is it accelerating PD research and improving how doctors care […]

Read More

New Parkinson’s Disease Treatments in the Clinical Trial Pipeline

Posted on by Rebecca Gilbert, MD, Ph.D.

Promising New Treatments for Parkinson’s: What’s in the Clinical Trial Pipeline? There remains an urgent unmet need for Parkinson’s...see more disease (PD) treatments that slow or halt the underlying neurodegenerative process that leads to disease progression. Much research is focused on this, with clinical trials underway. It is also critical that medications continue to be developed […]

Read More